Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vicarious SurgicalRBOT -7.01% Cash Ratio is 1.10 as of Mar. 2026, which is 91% below its 10-year median of 12.27. The stock has 2 warning signs investors should review. Among 841 Medical Devices & Instruments companies, Vicarious Surgical ranks better than 53.51% on this metric.
Vicarious Surgical has a Cash Ratio of 1.10. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Vicarious Surgical's Cash Ratio or its related term are showing as below:
RBOT'
s Cash Ratio Range Over the Past 10 Years
Min: 1.1 Med: 12.27 Max: 59.5
Current: 1.1
During the past 6 years, Vicarious Surgical's highest Cash Ratio was 59.50. The lowest was 1.10. And the median was 12.27.
RBOT's Cash Ratio is ranked better than 53.51% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 0.97
vs RBOT: 1.10
Vicarious Surgical (OTCPK:RBOT) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Vicarious Surgical Cash Ratio Related Terms
Vicarious Surgical Cash Ratio Historical Data
* Premium members only.
The historical data trend for Vicarious Surgical's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Vicarious Surgical's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vicarious Surgical Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vicarious Surgical's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Vicarious Surgical's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicarious Surgical (RBOT) has a Cash Ratio of 1.10 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Vicarious Surgical and its competitors. This is 91% below median its historical median of 12.27. Over the past decade, Vicarious Surgical's Cash Ratio has ranged from 1.10 to 59.50. According to the industry distribution chart, Vicarious Surgical ranks #391 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 46.5%.
Is Vicarious Surgical's Cash Ratio too high?
Vicarious Surgical's current Cash Ratio of 1.10 is 91% below median its 10-year median of 12.27. Over the past 10 years, this metric has ranged from a low of 1.10 to a high of 59.50. The Medical Devices & Instruments industry median Cash Ratio is 0.97. Vicarious Surgical's value of 1.10 is 13.4% above this industry median. Based on the distribution chart, Vicarious Surgical ranks #391 out of 841 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Vicarious Surgical's Cash Ratio compare to NUWE and ODYY?
According to the Medical Devices & Instruments industry distribution chart, Vicarious Surgical ranks #391 out of 841 companies for Cash Ratio. This puts Vicarious Surgical in the upper half of its industry. The industry median Cash Ratio is 0.97. Vicarious Surgical's value of 1.10 is 13.4% above this benchmark. Historically, Vicarious Surgical's own Cash Ratio has ranged from 1.10 to 59.50 over the past decade. While the company's 10-year median is 12.27 vs. the industry median of 0.97, Vicarious Surgical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.97, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vicarious Surgical's current Cash Ratio of 1.10 is 13.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Vicarious Surgical and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vicarious Surgical's current Cash Ratio is 1.10, which is 91% below median its own 10-year median of 12.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicarious Surgical stock overvalued right now?
Vicarious Surgical (RBOT) has a current Cash Ratio of 1.10. The current Cash Ratio is 1.10, which is 91% below median its 10-year median of 12.27 and 13.4% above the Medical Devices & Instruments industry median of 0.97. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Vicarious Surgical (RBOT), the current Cash Ratio is 1.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vicarious Surgical Inc is combining miniaturized robotics, computer science, sensing and 3D visualization to build a new category of intelligent and affordable single-port surgical robots that virtually transport surgeons inside the patient to perform minimally invasive surgery. Its single-port surgical robot, called the Vicarious Surgical System is being developed to provide attractive advantages to hospitals and ambulatory surgical centers, or ASCs, which it believes will drive rapid and widespread adoption. The company operates as one operating segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RBOT has been successfully added to your 
